COMBINATION THERAPY WITH NINTEDANIB AND PREDNISOLONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

被引：0
作者：
Kato, Motoyasu [1 ]
Nakamura, Takahiro [1 ]
Kurokawa, Kana [1 ]
Yamada, Tomoko [1 ]
Ihara, Hiroaki [1 ]
Takahashi, Fumiyuki [1 ]
Sasaki, Shinichi [2 ]
Takahashi, Kazuhisa [1 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Tokyo, Japan
[2] Juntendo Univ, Urayasu Hosp, Tokyo, Japan
来源：
RESPIROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO212
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [21] Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis
    Gillian M. Keating
    Drugs, 2015, 75 : 1131 - 1140
  • [22] Real life experience with nintedanib in patients with idiopathic pulmonary fibrosis
    Brunnemer, Eva
    Ehlers-Tenenbaum, Svenja
    Heussel, Calus Peter
    Warth, Arne
    Herth, Felix
    Kreuter, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [23] Tolerability and safety of nintedanib in elderly patients with idiopathic pulmonary fibrosis
    Uchida, Yoshinori
    Ikeda, Satoshi
    Sekine, Akimasa
    Katano, Takuma
    Tabata, Erina
    Oda, Tsuneyuki
    Okuda, Ryo
    Kitamura, Hideya
    Baba, Tomohisa
    Komatsu, Shigeru
    Ogura, Takashi
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 99 - 105
  • [24] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Luca Richeldi
    Martin Kolb
    Stéphane Jouneau
    Wim A. Wuyts
    Birgit Schinzel
    Susanne Stowasser
    Manuel Quaresma
    Ganesh Raghu
    BMC Pulmonary Medicine, 20
  • [25] Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis
    Keating, Gillian M.
    DRUGS, 2015, 75 (10) : 1131 - 1140
  • [26] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Richeldi, Luca
    Kolb, Martin
    Jouneau, Stephane
    Wuyts, Wim A.
    Schinzel, Birgit
    Stowasser, Susanne
    Quaresma, Manuel
    Raghu, Ganesh
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [27] Outcomes in Patients Receiving Nintedanib or Pirfenidone for Idiopathic Pulmonary Fibrosis
    Cottin, V.
    Spagnolo, P.
    Bonniaud, P.
    Nolin, M.
    Dalon, F.
    Kirchgassler, K.
    Chia, J.
    Kamath, T. V.
    Van Ganse, E.
    Belhassen, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [28] Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage
    Ryerson, Christopher J.
    Kolb, Martin
    Richeldi, Luca
    Lee, Joyce
    Wachtlin, Daniel
    Stowasser, Susanne
    Poletti, Venerino
    ERJ OPEN RESEARCH, 2019, 5 (02)
  • [29] SAFETY OF COMBINED PIRFENIDONE AND NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Flaherty, K. R.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    THORAX, 2017, 72 : A253 - A254
  • [30] Outcomes in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis
    Cottin, Vincent
    Spagnolo, Paolo
    Bonniaud, Philippe
    Nolin, Maeva
    Dalon, Faustine
    Chia, Jenny
    Kirchgassler, Klaus
    Kamath, Tripthi
    Van Ganse, Eric
    Belhassen, Manon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 121 - 121
12345